Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2016-09-23
|
| gptkbp:ATCCode |
L04AB04
|
| gptkbp:biosimilar |
gptkb:Humira
|
| gptkbp:brand |
adalimumab-atto
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:firstUSLaunch |
2023-01-31
|
| gptkbp:form |
pre-filled syringe
pre-filled autoinjector |
| gptkbp:genericName |
adalimumab-atto
|
| https://www.w3.org/2000/01/rdf-schema#label |
Amjevita
|
| gptkbp:indication |
gptkb:juvenile_idiopathic_arthritis
gptkb:Crohn's_disease gptkb:psoriatic_arthritis ulcerative colitis rheumatoid arthritis ankylosing spondylitis plaque psoriasis hidradenitis suppurativa |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Amgen
|
| gptkbp:mechanismOfAction |
TNF inhibitor
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:product |
gptkb:Humira
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:bfsParent |
gptkb:adalimumab
|
| gptkbp:bfsLayer |
7
|